Literature DB >> 19267859

Nerve growth factor modulation of the cavernous nerve response to injury.

Anthony J Bella1, Guiting Lin, Ching-Shwun Lin, Duane R Hickling, Christopher Morash, Tom F Lue.   

Abstract

INTRODUCTION: Surgical therapies for prostate cancer and other pelvic malignancies often result in neuronal damage and debilitating loss of sexual function due to cavernous nerve (CN) trauma. Advances in the neurobiology of growth factors have heightened clinical interest in the development of protective and regenerative neuromodulatory strategies targeting CN recovery following injury. AIM: The aim of this review was to offer an examination of current and future nerve growth factor (NGF) modulation of the CN response to injury with a focus on brain-derived nerve growth factor (BDNF), growth differentiation factor-5 (GDF-5), and neurturin (NTN).
METHODS: Information for this presentation was derived from a current literature search using the National Library of Medicine PubMed Services producing publications relevant to this topic. Search terms included neuroprotection, nerve regeneration, NGFs, neurotrophic factors, BDNF, GDF-5, NTN, and CNs. MAIN OUTCOME MEASURES: Basic science studies satisfying the search inclusion criteria were reviewed.
RESULTS: In this session, BDNF, atypical growth factors GDF-5 and NTN, and their potential influence upon CN recovery after injury are reviewed, as are the molecular pathways by which their influence is exerted.
CONCLUSIONS: Compromised CN function is a significant cause of erectile dysfunction development following prostatectomy and serves as the primary target for potential neuroprotective or regenerative strategies utilizing NGFs such as BDNF, GDF-5, and NTN, and/or targeted novel therapeutics modulating signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19267859      PMCID: PMC2706280          DOI: 10.1111/j.1743-6109.2008.01194.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  43 in total

1.  Brain-derived neurotrophic factor (BDNF) acts primarily via the JAK/STAT pathway to promote neurite growth in the major pelvic ganglion of the rat: part 2.

Authors:  Guiting Lin; Anthony J Bella; Tom F Lue; Ching-Shwun Lin
Journal:  J Sex Med       Date:  2006-09       Impact factor: 3.802

2.  The effect of intracavernosal growth differentiation factor-5 therapy in a rat model of cavernosal nerve injury.

Authors:  Thomas M Fandel; Anthony J Bella; Kavirach Tantiwongse; Maurice Garcia; Lora Nunes; Joachim W Thüroff; Emil A Tanagho; Jens Pohl; Tom F Lue
Journal:  BJU Int       Date:  2006-06-26       Impact factor: 5.588

3.  Glial cell line-derived neurotrophic factor is expressed in penis of adult rat and retrogradely transported in penile parasympathetic and sensory nerves.

Authors:  A Laurikainen; J O Hiltunen; S Vanhatalo; E Klinge; M Saarma
Journal:  Cell Tissue Res       Date:  2000-12       Impact factor: 5.249

Review 4.  Neuromodulatory therapy to improve erectile function recovery outcomes after pelvic surgery.

Authors:  Arthur L Burnett; Tom F Lue
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

Review 5.  The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatment.

Authors:  Aideen M Sullivan; Gerard W O'Keeffe
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

6.  Characterization of growth/differentiation factor 5 (GDF-5) as a neurotrophic factor for cultured neurons from chicken dorsal root ganglia.

Authors:  L M Farkas; S Scheuermann; J Pohl; K Unsicker; K Krieglstein
Journal:  Neurosci Lett       Date:  1997-10-31       Impact factor: 3.046

7.  Penile rehabilitation should become the norm for radical prostatectomy patients.

Authors:  John P Mulhall; Abraham Morgentaler
Journal:  J Sex Med       Date:  2007-05       Impact factor: 3.802

8.  Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury.

Authors:  R Kato; D Wolfe; C H Coyle; S Huang; J B Wechuck; W F Goins; D M Krisky; T Tsukamoto; J B Nelson; J C Glorioso; M B Chancellor; N Yoshimura
Journal:  Gene Ther       Date:  2007-07-05       Impact factor: 5.250

9.  Determinants of sexual satisfaction in men with prostate cancer.

Authors:  Christian J Nelson; Judy M Choi; John P Mulhall; Andrew J Roth
Journal:  J Sex Med       Date:  2007-07-18       Impact factor: 3.802

Review 10.  Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury.

Authors:  Anthony J Bella; Guiting Lin; Ilias Cagiannos; Tom F Lue
Journal:  Asian J Androl       Date:  2008-01       Impact factor: 3.285

View more
  18 in total

Review 1.  Approaches for neural tissue regeneration.

Authors:  Loïc Binan; Abdellah Ajji; Gregory De Crescenzo; Mario Jolicoeur
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739

2.  Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Shuxin Liang; Ankit A Desai; Stephen M Black; Haiyang Tang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Emerging tools for erectile dysfunction: a role for regenerative medicine.

Authors:  Lukman Hakim; Frank Van der Aa; Trinity J Bivalacqua; Petter Hedlund; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2012-07-24       Impact factor: 14.432

4.  Combined effects of brain-derived neurotrophic factor immobilized poly-lactic-co-glycolic acid membrane with human adipose-derived stem cells and basic fibroblast growth factor hydrogel on recovery of erectile dysfunction.

Authors:  Seung Hwan Lee; In Gul Kim; Ae Ryang Jung; Kshitiz Raj Shrestha; Jin Ho Lee; Ki Dong Park; Byung Ha Chung; Sae Woong Kim; Ki Hean Kim; Ji Youl Lee
Journal:  Tissue Eng Part A       Date:  2014-05-20       Impact factor: 3.845

Review 5.  Landmarks in erectile function recovery after radical prostatectomy.

Authors:  Emmanuel Weyne; Fabio Castiglione; Frank Van der Aa; Trinity J Bivalacqua; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2015-04-14       Impact factor: 14.432

6.  Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury.

Authors:  Maarten Albersen; Thomas M Fandel; Guiting Lin; Guifang Wang; Lia Banie; Ching-Shwun Lin; Tom F Lue
Journal:  J Sex Med       Date:  2010-10       Impact factor: 3.802

7.  Adipose tissue-derived stem cells secrete CXCL5 cytokine with neurotrophic effects on cavernous nerve regeneration.

Authors:  Haiyang Zhang; Rong Yang; Zhong Wang; Guiting Lin; Tom F Lue; Ching-Shwun Lin
Journal:  J Sex Med       Date:  2010-11-29       Impact factor: 3.802

8.  FK506 neuroprotection after cavernous nerve injury is mediated by thioredoxin and glutathione redox systems.

Authors:  Gwen Lagoda; Yi Xie; Sena F Sezen; K Joseph Hurt; Limin Liu; Biljana Musicki; Arthur L Burnett
Journal:  J Sex Med       Date:  2011-10-13       Impact factor: 3.802

9.  Flk-1⁺Sca-1⁻ mesenchymal stem cells: functional characteristics in vitro and regenerative capacity in vivo.

Authors:  Yugang Li; Enshan Pan; Yu Wang; Xiaoguang Zhu; Anyang Wei
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Effect of an adipose-derived stem cell and nerve growth factor-incorporated hydrogel on recovery of erectile function in a rat model of cavernous nerve injury.

Authors:  In Gul Kim; Shuyu Piao; Ji Young Lee; Sung Hoo Hong; Tae-Kon Hwang; Sae Woong Kim; Choung Soo Kim; Jeong Chan Ra; Insup Noh; Ji Youl Lee
Journal:  Tissue Eng Part A       Date:  2012-09-04       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.